News

Applied Clinical Trials Online9h
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...
The top reasons Ozempic users are going to the hospital — and the ‘Wild West’ factor that could be driving an unexpected issue
Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...
MPR2h
Oral Semaglutide 25mg Under Review for Chronic Weight Management
Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...
Managed Healthcare Executive3h
FDA Sets Action Date for Oral Wegovy for Weight Loss
A decision is expected in the fourth quarter of 2025.
HealthDay on MSN7h
Semaglutide Beneficial in Metabolic Dysfunction-Associated Steatohepatitis, Fibrosis
For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with ...
Fierce Pharma7h
Madrigal's Rezdiffra, the first-ever MASH drug, beats sales projections for 4 quarters in a row
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...
Medical Dialogues19h
Weekly Semaglutide Offers Long-Term Relief: Better Glycaemic Control and Less Insulin in Type 2 Diabetes, Study Finds
Italy: A recent multicentre real-world study supports the long-term effectiveness of once-weekly semaglutide as a valuable ...
Shed pounds before summer for just $50 with this semaglutide weight loss program
Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...